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Abstract
Although urothelial progenitor-like cells have been described in the human urinary tract, the existence of stem cells remains
to be proven. Using a culture system that favors clonogenic epithelial cell growth, we evaluated and characterized clonal
human urothelial cells. We isolated human urothelial cells that were clonogenic, capable of self-renewal and could develop
into fully differentiated urothelium once re-implanted into the subcapsular space of nude mice. In addition to final urothelial
cell differentiation, spontaneous formation of bladder-like microstructures was observed. By examining an epithelial stem
cell signature marker, we found p63 to correlate with the self-renewal capacity of the isolated human urothelial clonal
populations. Since a clinically relevant, long-term model for functional reconstitution of human cells does not exist, we
sought to establish a culture method for porcine urothelial cells in a clinically relevant porcine model. We isolated cells from
porcine ureter, urethra and bladder that were clonogenic and capable of self-renewal and differentiation into fully mature
urothelium. In conclusion, we could isolate human and porcine cell populations, behaving as urothelial stem cells and
showing clonogenicity, self-renewal and, once re-implanted, morphological differentiation.
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Introduction
Adult stem cells are currently used to treat patients with severe
burns and hematological diseases [1,2,3]. To date, such adult stem
cells displaying clonogenicity, self-renewal and differentiation
capacity have not been characterized in human urothelium.
Urothelial stem cells have been described in mice and were found
to express sonic-hedgehog proteins in the basal cell layers of the
bladder urothelium [4]. A more recent report has demonstrated
that mouse urothelial stem cells are p63-positive as well [5]. This
has not been shown in larger-animal models or humans, although
the existence of human urothelial progenitor-like cells have been
described in the human urinary tract by multiple groups [6,7].
Clonogenic cell growth, however, ultimately proving the existence
of human urothelial stem cells, has not been demonstrated in vitro.
In larger-animal models, both porcine and bovine urothelial cells
have been shown to be capable of forming colonies and to
differentiate in vitro [8,9].
To establish whether the human urinary tract possesses a stem
cell capable of clonogenicity, self-renewal and differentiation
in vivo, we used an established culture system for human epithelial
stem cells: the 3T3-J2 culture system [10]. In parallel, we also
explored porcine urothelial cells from different anatomical
locations of the urinary tract, to have a clinically relevant animal
model for investigations in urinary tract repair intended for human
patients. Our criteria for human and porcine urothelial stem cells
were clonogenicity, self-renewal in vitro and full urothelium
differentiation capacities in vivo.
Materials and Methods
Ethical Human and Animal Research Approval
Ethical approval for working with human biopsies was given by
the ethical board of the ‘‘Centre Hospitalier Universitaire
Vaudois’’ (CHUV, Lausanne, CH). Furthermore, urinary tract
biopsies were harvested following signed consent by the patients or
their guardians. The ‘‘Office Ve´te´rinaire Cantonal’’, Vaud,
Switzerland, approved all animal procedures.
3T3-J2 Cell Culture
Human and porcine urothelial cells were cultured on feeder
layers of lethally irradiated 3T3-J2 cells as previously described by
Rheinwald et al. [10]. 3T3-J2 fibroblasts in passage 4–12 were
cultivated in Dulbecco-Vogt’s modification of Eagle’s medium
(DMEM) (Life Technologies, CH) supplemented with 10% of fetal
bovine serum (Life Technologies, CH). 3T3-J2 fibroblasts were
grown in T162 flasks (Costar, USA) in a 10% CO2 atmosphere at
37uC 7 days after seeding, or when confluent. 3T3-J2 cells were
dissociated with 0.05% trypsin and 0.01% EDTA and re-seeded.
One day prior to seeding of the epithelial cells, 3T3-J2 cells were
lethally irradiated by gamma radiation (60 Gy dose, MDS
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Figure 1. Human clonal urothelial cells arising from single ureteral cell. (A) Schematics showing the passage from the single selected cell to
the in vivo implantated clonal cell pellet. (B,C and D) Human urothelial holoclone, meroclone and paraclone cultures arising from one single ureteral
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Nordion Gammacell 3000 irradiator, Best Theratronics, UK) and
seeded at a density of 26104 cells/cm2.
Human Urothelial Cell Isolation and Culture
Human urothelial cells were isolated from ureteral biopsies from
pediatric donors undergoing open surgeries for non-malignant
congenital anomalies (Table S1A). Primary human urothelial cell
isolation was carried out as previously described by Southgate et al.
[6]. The urinary tract biopsies were incubated for 16 h at 4uC in
HBSS buffer supplemented with 0.1% EDTA (Sigma, CH),
10 mM HEPES (Life Technologies, CH) and aprotinin (1X,
Roche, CH). Using forceps, the tissue was mechanically scraped.
Scraped tissue was incubated with 2 mL collagenase IV (100 U/
mL, Sigma, CH) at 37uC for 20 min. Finally, cells were strained
through a 100 mm cell-strainer (Falcon, BD, CH) before being
seeded onto the lethally irradiated 3T3-J2 cells. Human urothelial
cells were cultured in a 10% CO2 atmosphere at 37uC in cFAD
medium, which consists of DMEM and Ham’s F12 (Life
Technologies, CH) medium (v/v 3:1), supplemented with 20%
of fetal bovine serum (FBS) (Life Technologies, Australia), adenine
(24.3 mg/mL, Merck, CH), insulin (5 mg/mL, Sigma, CH), 3,3,5-
triiodo-L-thyronine (T3) (2610–9 M, Sigma, CH), hydrocortisone
(0.4 mg/mL, Sigma, CH), cholera toxin (1610–10 M, Sigma, CH),
and 1% penicillin/streptomycin (Life Technologies, CH). All
urothelial cultures were fed cFAD-containing FBS originating
from the same batch. The urothelial cells were fed with cFAD
supplemented with Epidermal growth factor (EGF) (10 ng/mL,
Roche, CH) every 4 days or when the medium became acidic.
Porcine Urothelial Cell Isolation and Culture
Porcine urinary tract biopsies for cell isolation were kindly
donated from the University of Bern Veterinarian School and the
CHUV. GFP-porcine urothelial cells were isolated from urinary
tract biopsies of a 12-month-old transgenic pig constitutively
expressing eGFP bought from the Institute of Molecular Animal
Breeding/Gene Center (LMU, Munich, Germany) [11]. Details of
the porcine donors can be found elsewhere (Table S1). Bladder
biopsies were taken from the bladder trigone and the bladder
dome, while urethral biopsies were taken from the proximal
urethra and ureteral biopsies were taken from mid distance
between the ureteral meatus and the kidney. Porcine epithelial
cells were isolated and cultured as previously described by Grasset
et al. [12]. Biopsies were minced into small pieces (1–3 mm2) and
incubated in a cell isolation solution (trypsin (0.02%), EDTA
(0.1%) and collagenase A (1 mg/mL, Roche, CH)) at 37uC under
gentle stirring. Every hour, the cell isolation solution was replaced.
Each batch of recovered cell isolation media was centrifuged
(1300 rpm, 5 min) and filtered through a 100 mm cell-strainer
before being seeded into dishes or flasks containing lethally
irradiated 3T3-J2 cells. Porcine epithelial cells were grown in the
same culture condition as the human urothelial cells, except using
10% of the same batch of FBS.
During harvesting of porcine tissues for cell isolation, biopsies of
native porcine tissues were taken and fixed in 10% natural
buffered formalin (NBF 10%). Paraffin embedded native porcine
tissues were later used as controls for immunohistochemistry.
Porcine skin epithelial tissue was used as negative control in
immunohistochemistry. Cultured porcine keratinocytes and thy-
mus cells were used as negative controls in immunofluorescence.
Mass-cultivation of Urothelial Cells
Mass-cultivated urothelial cells were seeded at a density of
56104–26105 cells into 30 mm, 60 mm or T25 flasks containing
lethally irradiated 3T3-J2 cells. Cells were passaged every week by
dissociating growing epithelial cells in 0.05% trypsin/0.1% EDTA
and then by re-plating them at the appropriate density to achieve
cell confluence within 7 days. Population doubling (PD) was
calculated using the following formula: PD=Log(N/N0)/Log(2),
where N0 is the number of seeded viable cells and N is the number
of viable cells at the time of passage counted, using a
hemocytometer.
Colony-forming Assay
Each time a new urothelial cell population was passaged, a
colony-forming assay was performed. The colony-forming assay
consisted of seeding urothelial cells at a density of 50 to 5000 cells
into duplicated 60 mm or 100 mm indicator culture dishes,
containing lethally irradiated 3T3-J2 cells. The cells were
cultivated for 12 days as described above, before being fixed in
NBF 10% and stained with rhodamine-B (1%, Sigma, Germany).
Colony-forming efficiencies (CFE) were calculated by dividing the
number of colonies by the initial number of seeded cells in each
plate.
Clonal Analysis
Single cells from passages 1–3 were aspirated into a Pasteur
pipette under a Zeiss Axiovert inverted microscope (Germany)
using a 10x objective and were subsequently inoculated into a
tissue culture dish containing lethally irradiated 3T3-J2 cells. Small
and round cells were selected following the rationale of Barrandon
et al [13]. Cultures were fed every 3–4 days with cFAD medium
supplemented with 10 ng/mL human recombinant EGF, as
described above. After 7 days, adherent single cells that formed
colonies were identified and imaged with an inverted microscope
(Zeiss, Germany). Areas of 7-day clones were measured with the
ImageJ software (Clonal Area=CA), while cell numbers in the 7-
day colonies were counted manually (Estimated cell number= -
Estim CN). Population doubling for each 7-day clones (Generation
number =GN) was calculated from using the same formula as
previously described in the method section, but with N0= 1 and
N=Estim CN. Generation time was calculated dividing the time
of culture (7 days = 168 h) with the generation number. Clones
were detached from the dishes with 0.05% trypsin and 0.01%
EDTA and re-seeded, 2 dishes were inoculated each with 1/7 of
cell suspensions obtained (for CFE). The rest ( = 5/7 of cell
suspensions) was inoculated for clonal population expansion
(Figure 1A).
Human and porcine clones arising from epidermal single cells
can be classified as holoclones, meroclones or paraclones
depending on the clone’s capacity to form aborted colonies
[12,14]. We used the following similar criteria to classify aborted
and growing urothelial colonies under a binocular microscope
defining ‘‘Growing’’ as having a colony diameter of $2 mm,
‘‘Aborted’’ of ,2 mm, and ‘‘Aborted’’ as having a highly irregular
colony shape.
Clones that formed 0–5% aborted colonies were classified as
urothelial holoclones. Conversely, if a clone formed 100% aborted
colonies or no colonies, it was classified as an urothelial paraclone.
cell. (E and F) Growth curve of a human urothelial holoclone (G) In vivo urothelial differentiation of human ureteral urothelial holoclone pellets
implanted into the subcapsular space of the Swiss nu/nu mice, expressing cytokeratin 7, uroplakin-2 and uroplakin 3 (scale bars, 10 mm). Note the
‘‘micro-bladder’’ like structure.
doi:10.1371/journal.pone.0090006.g001
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Figure 2. Urothelial cell differentiation and ‘‘micro-bladder’’ formation in mice. (A and B) Hematoxylin & eosin (H&E) staining of an
implanted mass-cultured, native porcine bladder urothelial cell pellet into the subcapsular space of a Swiss nu/nu mice kidney (A: scale bar 500 mm, B:
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Clones that formed more than 5% but fewer than 100% aborted
colonies were classified as urothelial meroclones.
Lentiviral Infection for Human Urothelial Cell GFP
Transduction
Titers of lentivirus containing the hPGK-GFP lentivector were
kindly donated from Professor D. Trono (EPFL, Switzerland).
1 mL of lentivirus (titer 5*109 TU/mL) was applied to 75%
confluent human urothelial cells cultured in 6 well plate at passage
1.
Immunohistochemistry/Fluorescence
Biopsies were fixed in 10% NBF and embedded in paraffin.
Sections were prepared at a thickness of 8 mm. Hematoxylin and
eosin staining was performed on all biopsies. Primary antibodies
used for immunohistochemistry/fluorescence were donkey anti-
goat uroplakin-2 (1:500 dilution, Labforce, CH), mouse anti-
uroplakin-3 (1:50 dilution, Progen, Germany), mouse anti-
cytokeratin 7 (1:1000 dilution, Abcam, CH), rabbit anti-GFP
(1:500 dilution, Life Technologies, CH), mouse anti-Ki67 (1:100
dilution, BD Pharmingen, CH) and mouse anti-p63 (1:100
dilution, Neomarker, US). Secondary antibodies used were
Alexa-Fluor 488, Alexa-Fluor 568, or Alexa-Fluor 647 (Molecular
Probes, Life Technologies, CH).
For immunofluorescence, cells were cultured on glass cover slips
in 12-well plates and fixed in 10% NBF (20 min, at 4uC) after 8–
12 days. Cells were permeabilized with 0.4% saponin (Applichem,
CH) in D-PBS (Life Technologies, CH) for 30 min. After blocking
for 1 h (3% BSA and 0.4% saponin in D-PBS), the cells were
incubated with primary antibodies at room temperature for 2 h.
After washing, the cells were incubated with secondary antibodies
for 2 h. After multiple washing steps, Hoechst 33342 (Life
Technologies, CH) was added to the cells and incubated for
10 min before imaging. Images were taken with a LSM 700
confocal laser-scanning microscope (Zeiss, Germany). For negative
controls, the primary antibody was omitted.
In vivo Nude Mice Experiments
The renal subcapsular space of Swiss nu/nu mice (Charles-
River Breeding laboratories, France) was used as an ectopic
location for implanted urothelial pelleted cells. The implanted
urothelial pelleted cells were a mix of 2.5*105 GFP positive
urothelial cells plus 2.5*105 non-lethally irradiated 3T3-J2 cells.
After 3 wk, kidneys were harvested and imaged with a fluores-
cence stereomicroscope (Leica, Germany) to locate GFP positive
cells. Kidneys were fixed in 10% NBF and embedded in paraffin
for histological analysis.
The dorsal subdermal space of Swiss nu/nu mice was also used
as an ectopic location for implanted urothelial sheets following the
technique described in Barrandon et al. [15]. The implanted sheets
consisted of 12 day cultured urothelial cells treated with Dispase-II
(Roche, CH), initially seeded at a density of 1*105 GFP positive
urothelial cells. After 3 wk, the subdermal implant was harvested
and imaged with a fluorescence stereomicroscope (Leica, Ger-
many) to locate GFP positive cells. The tissue segments were fixed
in 10% NBF and embedded in paraffin for histological analysis.
Results
Characterization of Mass-cultured Human and Porcine
Urothelial Cells
We observed that both human and porcine urothelial cells
arising from respective biopsies were capable of forming colonies
in culture (Figure S1). Urothelial cells of human native ureters as
well as native porcine bladder and ureter expressed uroplakin-2
and uroplakin-3 (Figure S2C, S3C, S4C and S5C). In contrast, the
urothelial cells of native porcine urethral tissue only expressed
uroplakin-2 but not uroplakin-3 (Figure S6C). We also found that
human and porcine urothelial cells cultured in vitro for 8 days
widely expressed a general marker of urothelial cells, cytokeratin-
7, but only expressed uroplakin-2 spot-wise in a sparse manner
(Figure S2D, S3D, S4D, S5D and S6D). However, none of the
human or porcine urothelial cells cultured in vitro for this period
expressed uroplakin-3 (Figure S2D, S3D, S4D, S5D and S6D).
We sought to develop an in vivo model to study full differenti-
ation of the urothelium. We tested two ectopic locations to implant
GFP positive porcine mass-cultured urothelial cells in Swiss nu/nu
mice. Dispase-treated sheets of urothelial cells cultured for 12 days
were implanted into the dorsal sub-dermal space of the nude mice
and were compared to urothelial cells implanted as a pellet under
the kidney capsule. We sacrificed the animals after 3 wk and
studied the expression of uroplakin-2 and uroplakin-3 in GFP
positive cells. The urothelial sheets on the back of the mice formed
a uniform sheet expressing uroplakin-2, but not uroplakin-3
(Figure S7). On the other hand the pellets implanted beneath the
renal capsule formed urothelial bundle-like and urothelial ‘‘micro-
bladder’’-like structures with a lumen (Figure 2A and 2B). Both of
these structures expressed uroplakin-2 and uroplakin-3 (Figure 2C).
Furthermore we observed that they expressed a proliferation
scale bar 50 mm, urothelial bundle-like structure indicated with black star and epithelial ‘‘micro-bladder’’ like structure indicated with red star). (C–H)
Immunohistochemistry of the implanted urothelial pellet forming urothelial bundle-like structures (C, E and G) and ‘‘micro-bladder’’ like structures (D,
F and H) using antibodies against uroplakin-2 (C and D), uroplakin-3 (E and F) and Ki-67 (G and H) (scale bars, 10 mm).
doi:10.1371/journal.pone.0090006.g002
Table 1. Clonal analysis of human ureteral cells.
Clone CA day 7 (mm2) Estim CN GT (h) GN CFE (%) GC (nb) AB (nb) AB (%) Clonal type
1 1.295 1634 15.7 10.6 31.2 97 5 4.90 Holoclone
2 0.733 1209 16.4 10.2 19.9 46 2 4.17 Holoclone
3 0.243 330 20.1 8.36 3.04 0 2 100 Paraclone
4 1.378 1243 16.3 10.3 6.84 3 14 82.3 Meroclone
5 1.294 2661 14.8 11.4 4.51 12 12 50.0 Meroclone
(CA = clone area, Estim CN=estimated cell number, GT = generation time, GN=generation number, GC = growing colony, nb =number, AB = aborted).
doi:10.1371/journal.pone.0090006.t001
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marker, Ki-67, suggesting that the GFP-urothelial cells were
proliferating beneath the kidney capsule (Figure 2C).
We found that porcine ureteral, urethral, bladder dome and
trigone cells grew well in the 3T3-J2 culture system, showing high
colony-forming efficiencies for all the isolated biopsies (indepen-
dent on age of donors) (Figure S3A–B, S4A–B, S5A–B and S6A–
B). We did not observe any major growth differences between the
different anatomical harvesting locations. Next, we investigated
whether the porcine ureteral, urethral, bladder dome and trigone
urothelial cells had similar differentiation capacities in the mouse
kidney capsule model. We observed that the porcine ureteral,
bladder dome and trigone cells formed fully differentiated
urothelium, expressing uroplakin-2 and uroplakin-3 (Figure S3E,
S4E and S5E). Interestingly, implanted urethral urothelial cells
expressed uroplakin-2, following the protein expression pattern of
native urethral tissue (Figure S6C and S6E), but as would be
expected did not express uroplakin-3. Confirming the specificity of
these antibodies for urothelium, we also found porcine skin
biopsies as well as 8-day in vitro cultured porcine keratinocytes and
thymus, to be negative for cytokeratin-7, uroplakin-2 and
uroplakin-3 (Figure S8).
Clonogenicity, Self-renewal in vitro and Urothelial
Differentiation in vivo of Human Urothelial Cells Isolated
from the Ureter
We explored whether handpicked cells with an elongated
Pasteur pipette under an inverted microscope could initiate clonal
growth. Following the rationale of Barrandon et al. [13], we
selected small and round urothelial cells, and observed the
development of clonal populations with different growth capaci-
ties. Applying the similar definitions for classifying the clonal type,
based on aborted colony percentages as previously used for human
epidermal, hair-follicle and corneal epithelial clonal cells
[14,16,17], we observed that the selected clonal populations
formed urothelial holoclones, meroclones and paraclones
(Figure 1B, 1C and 1D) (Table 1).
The human urothelial holoclone could not be serially passaged
longer than 25 population doublings with a decreased colony-
forming efficiency over 45 days of culture, after which senescence
occurred (Figure 1E and 1F). We observed that cells of human
urothelial holoclones stained strongly and homogenously for p63
at an early passage (passage 2), while at later passage (passage 5)
the urothelial holoclones expression of p63-expression was weak or
not even present in colonies (Figure 3A and 3B). Evident from
these images are the cell morphology differences going from a non-
stretched cell morphology at passage 2 (characteristic of a
proliferative urothelial phenotype) to a stretched cell morphology
at passage 5 (characteristic of a differentiated/senescent urothelial
cell phenotype) (Figure 3A and 3B). When we examined urothelial
meroclones at an early passage (passage 2), we observed mixed
p63-expression, ranging from strong, weak to no expression
(Figure 3C). Interestingly, in human ureter biopsies we saw a
strong p63-expression in the basal cells in the urothelium, a weak
Figure 3. p63 expression in clonal human urothelial cells and urothelium. (A) p63-expression in a human urothelial holoclone culture at
passage 2. (B) p63-expression in a human urothelial holoclone culture at passage 5. (C) p63-expression in a human urothelial meroclone culture at
passage 2. (D) p63-expression in a human ureter biopsy (scale bars, 10 mm). Note the DAPI positive together with GFP negative cells are 3T3-J2 cells
and DAPI positive together with GFP positive cells are urothelial cells.
doi:10.1371/journal.pone.0090006.g003
Table 2. Clonal analysis of porcine ureteral cells.
Clone CA day 7 (mm2) Estim CN GT (h) GN CFE (%) GC (nb) AB (nb) AB (%) Clonal type
1 0.875 721 17.7 9.49 99.9 142 2 1.38 Holoclone
2 1.405 895 17.1 9.81 67.0 118 3 2.48 Holoclone
3 0.891 304 20.4 8.24 4.95 0 3 100 Paraclone
4 1.765 1310 16.2 10.4 39.3 54 49 47.6 Meroclone
5 0.284 639 18.0 9.32 33.7 21 22 51.2 Meroclone
(CA = clone area, Estim CN=estimated cell number, GT = generation time, GN=generation number, GC = growing colony, nb =number, AB = aborted).
doi:10.1371/journal.pone.0090006.t002
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p63-expression in the intermediate cells and no p63 expression in
the superficial cells (Figure 3D).
When we implanted the GFP-positive human urothelial
holoclones in the kidney capsule model, we also found that these
had the capacity to form ‘‘micro-bladder’’-like structures, express-
ing uroplakin-2 and uroplakin-3, protein markers for fully
differentiated urothelium (Figure 1G).
Clonogenicity, Self-renewal in vitro and Urothelial
Differentiation in vivo of Porcine Urothelial Cells Isolated
from the Ureter, Bladder and Urethra
Studying the in vitro behavior of cells harvested from the porcine
bladder, ureter and urethra, we observed the same clonogenic
capacity as the cells harvested from the human ureter. Porcine
clonogenic urothelial cells were, as for the human cells, classified as
urothelial holoclones, meroclones or paraclones, depending on the
growth capacities. (Figure 4A–C, 5A–C and 6A–C) (Table 2, 3
and 4). Compared to human holoclones, porcine holoclones had a
much greater growth capacity. It could be demonstrated that after
38 days of passaging, porcine urothelial holoclone showed 30
population doublings and thereafter were still in a growing phase
(Figure 4D–E, 5D–E and 6D–E).
Next we analyzed the differentiation capacity of the porcine
bladder-, porcine ureter-, and porcine urethra-holoclones in the
kidney capsule model. We observed that all the implanted
holoclones had the capacity to form ‘‘micro-bladder’’-like struc-
tures. The porcine ureteral- and bladder-holoclones expressed
both uroplakin-2 and uroplakin-3 (4F and 5F). Interestingly, in one
of the three kidneys harvested from animals with implanted
urethral holoclones, one micro-bladder was observed to express
uroplakin-3 (Figure 6G), however, all other micro-bladders formed
by the urethral holoclones only expressed uroplakin-2 and not
uroplakin-3 (Figure 6F).
Discussion
Human and porcine cell populations derived from a single
urothelial cell, can self-renew in vitro and differentiate into mature
urothelium in vivo, and therefore represent clonogenic urothelial
stem cell populations. First, we aimed at reproducing the findings
that urothelial cells had the capacity to form colonies at low cell
seeding density when seeded using the 3T3-J2 culture system, as
reported by Wu in the 1980’s [18]. These results encouraged us to
perform clonal analysis of urothelial cells. The commonly applied
urothelial cell culture technique uses a feeder cell-free culturing
system [6], which does not allow clonal cell analysis. Using the
3T3-J2 culture system, we demonstrated that both human and
porcine urothelial cells could initiate colony growth when seeded
at low densities and clonal cell populations based on single cell
seeding. However, the decrease of CFE, the premature change of
morphology together with the loss of p63 expression indicates that
the 3T3-J2 culture system can be improved for human urothelial
stem cells expansion.
Further we evaluated if cultured urothelial cells can differentiate
into a superficial urothelial cell type, representing the mature
urothelial umbrella cells, being in contact with urine. In these cells,
uroplakins are the main responsible molecules for the barrier
function, forming protein plaques and preventing the urine from
entering surrounding tissues. The uroplakin family consists of four
proteins that make up these plaques, consisting of pairs of
uroplakin-1a with uroplakin-2 and uroplakin-1b with uroplakin-3
[19]. We observed that after implantation of human and porcine
urothelial cell pellets, generated from a single urothelial cells, into
the renal subcapsular space of Swiss nu/nu mice, uroplakin-2 and
uroplakin-3 expression were initiated. However, implanting
urothelial sheets into the dorsal subdermal space of nude mice,
only the expression of uroplakin-2 but not of uroplakin-3 was
observed during the observation period of 3 weeks. It seems that
urothelial cell pellets implanted into the renal subcapsular space
favor differentiation into mature urothelial cells, making it a more
suitable assay to study urothelial differentiation. We noticed that
Table 3. Clonal analysis of porcine bladder cells.
Clone CA day 7 (mm2) Estim CN GT (h) GN CFE (%) GC (nb) AB (nb) AB (%) Clonal type
1 8.372 2500 14.9 11.3 56.0 272 8 2.86 Holoclone
2 0.098 185 22.3 7.53 81.1 29 1 3.33 Holoclone
3 0.009 12 46.9 3.58 83.3 0 2 100 Paraclone
4 0.035 90 25.9 6.49 55.5 8 2 20.0 Meroclone
5 0.155 140 23.6 7.13 39.3 8 3 27.3 Meroclone
(CA = clone area, Estim CN=estimated cell number, GT = generation time, GN=generation number, GC = growing colony, nb =number, AB = aborted).
doi:10.1371/journal.pone.0090006.t003
Table 4. Clonal analysis of porcine urethral cells.
Clone CA day 7 (mm2) Estim CN GT (h) GN CFE (%) GC (nb) AB (nb) AB (%) Clonal type
1 1.156 990 16.9 9.95 79.9 151 7 4.43 Holoclone
2 0.072 220 21.6 7.78 2.28 0 1 100 Paraclone
3 0.069 371 19.7 8.53 13.5 5 5 50.0 Meroclone
4 0.140 289 20.6 8.17 27.7 12 4 25.0 Meroclone
(CA = clone area, Estim CN=estimated cell number, GT = generation time, GN=generation number, GC = growing colony, nb =number, AB = aborted).
doi:10.1371/journal.pone.0090006.t004
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uroplakin-3 expression was only found after vacuole formation
within urothelial bundle structures and at a later state within the
‘‘micro-bladder’’ like structures but not in the tight urothelial
bundles. It can be speculated that an up-regulation of the PPARc
signal pathway and a down-regulation of EGF-pathway seen in
in vitro cultured urothelial cells is due to the 3T3-J2 cells in the cell
pellet [20]. We have not observed that rat or human thymic
epithelial cells form these ‘‘micro-bladder’’ structures when
implanted into the renal subcapsular space [21]. Indicating the
‘‘micro-bladder’’ like structures are specific for implanting
urothelial cells. However, in literature it has been described that
mouse embryonic stem cells are able to form similar ‘‘micro-
bladder’’ like structures, when implanted together with micro
dissected embryonic rat urogenital sinus into the renal subcapsular
space [22]. Mouse bladder urothelial cells together with embryonic
rat urogenital sinus also forms the ‘‘micro-bladder’’ like structures
[23]. From these data it seems that ‘‘micro-bladder’’ like
structures, can be formed either with 3T3-J2 cells or micro
dissected embryonic rat urogenital sinus as carriers.
We aimed to establish whether there is a difference in porcine
urothelial cell growth and differentiation capacities between
different cell harvesting locations, as previously reported for
bovine urothelial cells by Liang et al. [9]. This might become
important if isolation of urothelial cells from a disease-free location
of the urinary tract is performed to replace neoplastic or diseased
tissues. From our porcine in vitro and in vivo data, we could not
observe any difference in cell growth and differentiation between
cells harvested from the ureter and the bladder. The in vitro cell
growth and differentiation capacity of urothelial cells harvested
from the urethra was comparable to the one of cells harvested
Figure 4. Porcine clonal urothelial cells arising from a single ureteral cell. (A, B and C) Porcine urothelial holoclone, meroclone and
paraclone cultures arising from a single ureteral cell. (D and E) Growth curves of a porcine urothelial holoclone. (F) In vivo urothelial differentiation of
porcine ureteral urothelial holoclone pellets implanted into the subcapsular space of the Swiss nu/nu mice, expressing cytokeratin 7, uroplakin-2 and
uroplakin 3 (scale bars, 10 mm). Note the ‘‘micro-bladder’’ like structure.
doi:10.1371/journal.pone.0090006.g004
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from the bladder. However, we observed that native urethral
biopsies and the implanted mass-cultured urethral cells did not
express uroplakin-3 in Swiss nu/nu mice, apart from the
expression in one single ‘‘micro-bladder’’-like structure, arising
from a urethral holoclone. This lets us assume that urothelial
umbrella cells arising from urethral holoclones can express
uroplakin-3 if implanted underneath the kidney capsule, although
it is not expressed in the native urethra. Indicating that urethral
holoclones can under certain condition have a broaden differen-
tiation capacity.
We also investigated if there is a difference in the behavior of
urothelial cells harvested from the bladder dome or the trigone. As
Figure 5. Porcine clonal urothelial cells arising from a single bladder cell. (A, B and C) Porcine urethelial holoclone, meroclone and
paraclone cultures arising from a single bladder cell. (D and E) Growth curves of a porcine urothelial holoclone. (F) In vivo urothelial differentiation of
porcine bladder urothelial holoclone pellets implanted into the subcapsular space of the Swiss nu/nu mice, expressing cytokeratin 7, uroplakin-2 and
uroplakin 3 (scale bars, 10 mm). Note the ‘‘micro-bladder’’ like structure.
doi:10.1371/journal.pone.0090006.g005
Novel Urothelial Stem Cell Population
PLOS ONE | www.plosone.org 9 February 2014 | Volume 9 | Issue 2 | e90006
Figure 6. Porcine clonal urothelial cells arising from a single urethral cell. (A, B and C) Porcine urethelial holoclone, meroclone and
paraclone cultures arising from a single urethral cell. (D and E) Growth curves of a porcine urothelial holoclone. (F, G) In vivo urothelial differentiation
of porcine urethral urothelial holoclonal cell pellets implanted into the subcapsular space of the Swiss nu/nu mice, expressing cytokeratin 7,
uroplakin-2 and uroplakin 3 (scale bars, 10 mm). Note the ‘‘micro-bladder’’ like structure.
doi:10.1371/journal.pone.0090006.g006
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it has been reported that urothelial cancers often develops in the
trigone, it could be speculated that the trigonal region has an
increased stem cell pool and would therefore be optimal for cell
harvesting [24]. However, we observed no difference in the cell
growth and differentiation capacity of cells from the two harvest
locations. These data correlate well with histological assessments of
the human bladder, where clonal patches were found to replenish
urothelium in all regions of the bladder, and not particularly from
the trigone [25].
Porcine clonogenic urothelial cells seem to favor the 3T3-J2
culture system for continuous self-renewal, in contrary to human
clonogenic urothelial cells. We can exclude a potential lentiviral
bias for the human urothelial senescence since also non-
transduced clonogenic human urothelial cells senesced. Thus, we
observe an epithelial tissue difference between human keratino-
cytes and human urothelial cells, where in vitro cultured human
clonal keratinocytes can reach 180 population doublings while
clonal human urothelial cells can only reach 25 population
doublings [26]. We argue that this is not only because of the 3T3-
J2 culture system is optimized for keratinocyte growth, but that
normal in vivo human urothelium cell turnover is also estimated to
be slower (6–11 months), and inherently human urothelial cells
should have a lower growth potential than the human keratino-
cytes (20 days epidermal cell turnover) [27,28]. However, the 3T3-
J2 culture system allows us, during a period of two weeks, to
evaluate human urothelial cell self-renewal and to study which
molecular signatures, such as p63, are important for self-renewal
[29]. Since p63 has been reported in keratinocyte and cornea
holoclones and more recently has been implicated as an in vivo
signature of mouse bladder stem cells, we saw this as a likely
molecular signature of human urothelial holoclones [5,30,31].
Proliferation data from holoclones showed that they senesced at a
late passage and this correlated with a mixed and weak expression
of p63 in the few occurring urothelial colonies. However, the
urothelial holoclones at an early passage (in a self-renewing phase)
expressed p63 homogenously and strongly in the urothelial
colonies. We also observed that the clonal hierarchy reflected
the level of p63 expression, where the holoclone had a more
homogenous expression of p63 compared to the meroclone. It is
tempting to infer from the biopsy data of p63 expression in native
human ureter, where the p63 expression from basal to superficial
cell goes from high to none, that the urothelial holoclones are
derived from the basal layer of the urothelium and that the in vitro
3T3-J2 culture system reflects what we partially observe in vivo,
similar to what has been described for skin model system [30]. We
believe that further investigation in understanding the molecular
mechanism for continuous human urothelial self-renewal is of
importance to learn to retain stemness in long-term cell culture,
which could be useful for potential clinical regenerative medicine
applications.
We further plan to implant clonal cell populations into an
orthotopic bladder model to determine if they can induce long-
term functional reconstitution. Due to ethical concerns, clinical
trials must be preceded by porcine functional reconstitution
studies. Our finding that clonogenic porcine urothelial cells can be
captured in vitro will allow us to perform long-term functional
reconstitution experiments to determine how these single cell
populations behave.
To date, only epidermal, corneal and blood-derived adult stem
cell populations have been successfully used in long-term
functional reconstitution for the treatment of severe diseases in
human patients [1,2,3]. Our results suggest that clonogenic
urothelial stem cell populations could potentially represent an
additional adult stem cell population, to be used for functional
regeneration of the diseased human urinary tract.
Conclusions
Human clonogenic urothelial stem cells have not previously
been studied in vitro or in vivo. We showed that isolated clonogenic,
human ureteral urothelial cells are able to self-renew in vitro and to
fully differentiate in vivo. Future larger-animal functional reconsti-
tution studies of in vitro cultured clonogenic urothelial stem cells
will be useful before initiating clinical trials in human patients.
Toward this end, we showed that porcine clonogenic urothelial
stem cells exist and therefore can be used for such studies.
Supporting Information
Figure S1 Colony forming capacity of mass-cultured
human and porcine urothelial cells. (A) Isolated human
ureteral cells, (B) porcine ureteral cells, (C) porcine urethral cells,
(D and E) porcine bladder dome and trigonal cells.
(TIF)
Figure S2 In vitro and in vivo behavior of mass-
cultured human ureteral cells. (A and B) Growth curves
and colony forming capacity of isolated human ureteral urothelial
cells. (C) Cytokeratin 7, uroplakin-2 and uroplakin-3 expression in
native human ureteral tissue. (D) Cytokeratin 7, uroplakin-2 and
uroplakin-3 expression of in vitro cultured human ureteral
urothelial cells after 8 days. (E) Cytokeratin 7, uroplakin-2 and
uroplakin-3 expression of in vivo implanted human ureteral
urothelial cells after 3 wk (scale bars, 20 mm).
(TIF)
Figure S3 In vitro and in vivo behavior of mass-
cultured porcine ureteral cells. (A and B) Growth curves
and colony forming capacity of isolated porcine ureteral urothelial
cells. (C) Cytokeratin 7, uroplakin-2 and uroplakin-3 expression in
native porcine ureteral tissue. (D) Cytokeratin 7, uroplakin-2 and
uroplakin-3 expression of in vitro cultured porcine ureteral
urothelial cells after 8 days. (E) Cytokeratin 7, uroplakin-2 and
uroplakin-3 expression of in vivo implanted porcine ureteral
urothelial cells after 3 wk (scale bars, 20 mm).
(TIF)
Figure S4 In vitro and in vivo behavior of mass-
cultured porcine bladder dome cells. (A and B) Growth
curves and colony forming capacity of isolated porcine bladder
dome urothelial cells. (C) Cytokeratin 7, uroplakin-2 and
uroplakin-3 expression in native porcine bladder dome tissue.
(D) Cytokeratin 7, uroplakin-2 and uroplakin-3 expression of
in vitro cultured porcine bladder dome urothelial cells after 8 days.
(E) Cytokeratin 7, uroplakin-2 and uroplakin-3 expression of in vivo
implanted porcine bladder dome urothelial cells after 3 wk (scale
bars, 20 mm).
(TIF)
Figure S5 In vitro and in vivo behavior of mass-
cultured porcine bladder trigone cells. (A and B) Growth
curves and colony forming capacity of isolated porcine bladder
trigone urothelial cells. (C) Cytokeratin 7, uroplakin-2 and
uroplakin-3 expression in native porcine bladder trigone tissue.
(D) Cytokeratin 7, uroplakin-2 and uroplakin-3 expression of
in vitro cultured porcine bladder trigone urothelial cells after 8
days. (E) Cytokeratin 7, uroplakin-2 and uroplakin-3 expression of
in vivo implanted porcine bladder trigone urothelial cells after 3 wk
(scale bars, 20 mm).
(TIF)
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Figure S6 In vitro and in vivo behavior of mass-
cultured porcine urethral cells. (A and B) Growth curves
and colony forming capacity of isolated porcine urethral urothelial
cells. (C) Cytokeratin 7, uroplakin-2 and uroplakin-3 expression in
native porcine urethral tissue. (D) Cytokeratin 7, uroplakin-2 and
uroplakin-3 expression of in vitro cultured porcine urethral
urothelial cells after 8 days. (E) Cytokeratin 7, uroplakin-2 and
uroplakin-3 expression of in vivo implanted porcine urethral
urothelial cells after 3 wk (scale bars, 20 mm).
(TIF)
Figure S7 Back skin model for in vivo urothelial
differentiation. (A and B) Hematoxylin & eosin (H&E) staining
of an implanted urothelial sheet into the dorsal subdermal space of
Swiss nu/nu mice (A: scale bar 500 mm, B: scale bar 50 mm). (C
and D) Immunohistochemistry of an implanted urothelial sheet
using antibodies against uroplakin-2 and uroplakin-3. Note no
uroplakin-3 expression (D).
(TIF)
Figure S8 Immunohistochemistry of skin and thymus
acting as negative control. (A) Cytokeratin 7, uroplakin-2 and
uroplakin-3 expression in native porcine skin tissue. (B) Cytoker-
atin 7, uroplakin-2 and uroplakin-3 expression of in vitro cultured
porcine keratinocytes after 8 days. (C) Cytokeratin 7, uroplakin-2
and uroplakin-3 expression of in vitro cultured porcine epithelial
thymus epithelial cells after 8 days.
(TIF)
Table S1 Tissue donor information. (A) Human donor
information. (B) Porcine donor information.
(TIF)
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